XTL Biopharmaceuticals Ltd. (XTLB)
NASDAQ: XTLB · Real-Time Price · USD
2.510
-0.120 (-4.56%)
At close: Mar 27, 2026, 4:00 PM EDT
2.510
0.00 (0.00%)
After-hours: Mar 27, 2026, 5:17 PM EDT
XTL Biopharmaceuticals Market Cap
XTL Biopharmaceuticals has a market cap or net worth of $22.12 million as of March 27, 2026. Its market cap has increased by 13.72% in one year.
Market Cap
22.12M
Enterprise Value
23.01M
1-Year Change
13.72%
Ranking
Category
Stock Price
$2.51
Market Cap Chart
Since August 31, 2005, XTL Biopharmaceuticals's market cap has decreased from $179.98M to $22.12M, a decrease of -87.71%. That is a compound annual growth rate of -9.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 6.35M | -10.85% |
| Dec 31, 2025 | 7.12M | -68.18% |
| Dec 31, 2024 | 22.38M | 322.69% |
| Dec 31, 2023 | 5.30M | -16.54% |
| Dec 29, 2022 | 6.35M | -57.67% |
| Dec 30, 2021 | 14.99M | -4.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lantern Pharma | 24.94M |
| Cue Biopharma | 24.89M |
| Vistagen Therapeutics | 24.42M |
| NeuroSense Therapeutics | 24.38M |
| Neuphoria Therapeutics | 24.31M |
| Tempest Therapeutics | 23.59M |
| IGC Pharma | 23.50M |
| Barinthus Biotherapeutics | 22.71M |